Uncategorized files

Showing below up to 50 results in range #58,751 to #58,800.

• 
  Telaprevir 3.jpg 1,041 × 296; 76 KB
  
• 
  Telaprevir 4-vert.jpg 1,032 × 2,477; 1.2 MB
  
• 
  Telaprevir 5.jpg 1,042 × 279; 82 KB
  
• 
  Telaprevir 6.jpg 1,039 × 89; 29 KB
  
• 
  Telaprevir 7.png 793 × 593; 335 KB
  
• 
  Telaprevir 8.png 694 × 596; 373 KB
  
• 
  Telaprevir 9.jpg 1,111 × 238; 67 KB
  
• 
  Telavancin.png 1,459 × 1,109; 39 KB
  
• 
  Telavancin hydrochloride 250 mg.png 634 × 650; 328 KB
  
• 
  Telavancin hydrochloride 750 mg.png 634 × 711; 333 KB
  
• 
  Telavancin hydrochloride All-Cause Mortality at Day 28 in Patients with at least One Baseline Gram-Positive Pathogen.png 627 × 563; 74 KB
  
• 
  Telavancin hydrochloride Baseline Infection Types in Patients in cSSSI.png 624 × 337; 35 KB
  
• 
  Telavancin hydrochloride Clinical Cure Rates at the Test-of-Cure for the Most Common Pathogens in cSSSI Trials 1 and 2.png 620 × 523; 67 KB
  
• 
  Telavancin hydrochloride Clinical Cure at Test-of-Cure in cSSSI Trials 1 and 2.png 622 × 316; 40 KB
  
• 
  Telavancin hydrochloride Clinical Response Rates in Trials 1 and 2 – AT and CE Populations.png 620 × 413; 47 KB
  
• 
  Telavancin hydrochloride Coagulation Tests Affected and Unaffected by Telavancin.png 613 × 262; 33 KB
  
• 
  Telavancin hydrochloride Complicated Skin and Skin Structure Infections.png 628 × 570; 51 KB
  
• 
  Telavancin hydrochloride Decreased Clinical Response in Patients with cSSSI and Pre-existing Renal Impairment.png 634 × 213; 21 KB
  
• 
  Telavancin hydrochloride FDA package label.png 624 × 1,909; 170 KB
  
• 
  Telavancin hydrochloride HABP-VABP.png 624 × 422; 53 KB
  
• 
  Telavancin hydrochloride HABP-VABP adverse reactions.png 618 × 221; 24 KB
  
• 
  Telavancin hydrochloride chemical structure.png 298 × 243; 29 KB
  
• 
  Telavancin hydrochloride pharmacodynamics.png 619 × 331; 34 KB
  
• 
  Telavancin hydrochloride pharmacokinetics.png 629 × 570; 48 KB
  
• 
  Telavancin hydrochloride structure.png 366 × 159; 16 KB
  
• 
  Telbivudine00.png 220 × 217; 5 KB
  
• 
  Telbivudine01.png 607 × 262; 29 KB
  
• 
  Telbivudine02.png 607 × 895; 61 KB
  
• 
  Telbivudine03.png 609 × 532; 54 KB
  
• 
  Telbivudine04.png 612 × 305; 33 KB
  
• 
  Telbivudine05.png 609 × 405; 42 KB
  
• 
  Telbivudine06.png 613 × 616; 63 KB
  
• 
  Telbivudine07.png 750 × 442; 28 KB
  
• 
  Telbivudine08.png 633 × 4,515; 496 KB
  
• 
  Telbivudine09.png 637 × 1,824; 289 KB
  
• 
  Telbivudine10.png 178 × 289; 63 KB
  
• 
  Telbivudine11.png 255 × 459; 97 KB
  
• 
  Telbivudine12.png 619 × 2,382; 137 KB
  
• 
  Telbivudine13.png 170 × 156; 12 KB
  
• 
  Telbivudine 1.jpg 143 × 128; 4 KB
  
• 
  Telbivudine 2.jpg 635 × 150; 41 KB
  
• 
  Telbivudine 3.jpg 665 × 212; 55 KB
  
• 
  Telbivudine 4.jpg 521 × 479; 85 KB
  
• 
  Telbivudine 5.jpg 598 × 277; 67 KB
  
• 
  Telbivudine 6.jpg 636 × 348; 71 KB
  
• 
  Telbivudine 7.jpg 768 × 157; 46 KB
  
• 
  Telbivudine 8.jpg 187 × 293; 19 KB
  
• 
  Telbivudine 9.jpg 258 × 468; 34 KB
  
• 
  Teleglucerase alpha image.jpg 672 × 282; 41 KB
  
• 
  Teleglucerase alpha ingredients and appearance.png 623 × 1,170; 104 KB